Noticias de RNA_US

Noticias del mercado

Últimas noticias sobre RNA_US — 35 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: RNA_US ✕ 35 resultados
26/04/2026 RNA_US — MSN
Avidity Biosciences prices $600M stock offering
24/04/2026 RNA_US — MSN
Avidity Biosciences reports data from DMD treatment trials
16/03/2026 RNA_US — Bloomberg
Novartis Offers High-Grade Debt to Fund $12 billion Avidity Deal
09/03/2026 RNA_US — Stock Titan
RNAM Stock Price, News & Analysis
02/03/2026 RNA_US — BioWorld News
Atrium Tx launches with Avidity's RNA ticker and cardio assets
27/02/2026 RNA_US — MarketBeat
Avidity Biosciences, Inc. $RNA Shares Bought by JPMorgan Chase & Co.
27/02/2026 RNA_US — PR Newswire
Atrium Therapeutics Launches with Approximately $270 Million to Advance Novel RNA Medicines for Rare Genetic Cardiomyopathies
27/02/2026 RNA_US — Yahoo Finance
Novartis successfully completes acquisition of Avidity Biosciences, strengthening late-stage neuroscience pipeline and advancing xRNA strategy
27/02/2026 RNA_US — Investing.com
Novartis completes $12 billion Avidity Biosciences acquisition
27/02/2026 RNA_US — Investing.com
Novartis completes acquisition of Avidity Biosciences; shares to be delisted from Nasdaq
27/02/2026 RNA_US — Stock Titan
Avidity Biosciences (RNA) CLO disposes stock, options in Novartis merger
27/02/2026 RNA_US — Stock Titan
Avidity Biosciences (RNA) taken private as Novartis merger closes, delisting set
27/02/2026 RNA_US — Yahoo Finance
Avidity (RNA) Moves Date for Shareholder Vote on Novartis Merger
27/02/2026 RNA_US — Stock Titan
Merger cashout for Avidity Biosciences (RNA) director Simona Skerjanec
27/02/2026 RNA_US — TradingView
Avidity Biosciences Ends ATM Sales Agreement With TD Securities Following Novartis Merger Close
27/02/2026 RNA_US — Stock Titan
[Form 4] Avidity Biosciences, Inc. Insider Trading Activity
27/02/2026 RNA_US — Stock Titan
Merger cash-out: Avidity Biosciences (RNA) officer’s options and shares disposed
27/02/2026 RNA_US — Stock Titan
Avidity Biosciences (RNA) CTO equity disposed in $72 Novartis merger
27/02/2026 RNA_US — Stock Titan
Novartis buyout: Avidity Biosciences (NASDAQ: RNA) director’s equity cashed out
26/02/2026 RNA_US — PR Newswire
Avidity Biosciences Announces Multiple Upcoming Presentations at 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference

Página 1 de 2

keyboard_arrow_up